Jump to content

Draft:Cyprolidol

From Wikipedia, the free encyclopedia


Cyprolidol
Clinical data
Other namesIN 1060
Identifiers
  • diphenyl-(2-pyridin-4-ylcyclopropyl)methanol
CAS Number
  • 7433-09-2
    [2364-72-9] (hydrochloride),
    [4904-00-1]
    (±)-trans/(1RS,2SR)
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC21H19NO
Molar mass301.389 g·mol−1
3D model (JSmol)
  • C1C(C1C(C2=CC=CC=C2)(C3=CC=CC=C3)O)C4=CC=NC=C4
  • InChI=1S/C21H19NO/c23-21(17-7-3-1-4-8-17,18-9-5-2-6-10-18)20-15-19(20)16-11-13-22-14-12-16/h1-14,19-20,23H,15H2
  • Key:KPUSUIKQQCFQCX-UHFFFAOYSA-N

Cyprolidol is an experimental antidepressant drug that was developed by Neisler Laboratories in the 1960s.[1] It was never approved for human use.

In preclinical studies, cyprolidol demonstrated antidepressant effects in animal models that were qualitatively similar to those of imipramine, a well-established tricyclic antidepressant.[2][3] However, clinical observations indicated that cyprolidol was less effective than imipramine in humans.[4] Pharmacologically, cyprolidol also exhibited cardiovascular effects, such as blocking the tyramine-induced rise in blood pressure in anesthetized dogs while potentiating this response in conscious dogs, suggesting a complex interaction with adrenergic systems.[5]

Its synthesis is similar to tranylcypromine a monoamine oxidase inhibitor.

Synthesis

[edit]
Cyprolidol synthesis:[6][7][8][9]

The cyclopropanation reaction between 4-vinylpyridine [100-43-6] (1) and the carbene from decomposition of ethyl diazoacetate [623-73-4] (2) would give ethyl 2-pyridin-4-ylcyclopropane-1-carboxylate [4903-93-9] (3). For steric reasons, the trans isomer would be the thermodynamically favoured racemer, although epimerization may be needed if this was not the kinetically formed product. The Grignard reaction of two equivalents of phenylmagnesium bromide [100-58-3] (4) to the electrophilic ester completes the synthesis of cyprolidol (5).

References

[edit]
  1. ^ "Cyprolidol hydrochloride". Inxight Drugs. National Center for Advancing Translational Sciences (NCATS), U.S. National Institutes of Health.
  2. ^ Brown ML, Gershon S, Korol B (1966). "Some pharmacological effects of a new potential antidepressant cyprolidol (IN-1060) compared with imipramine". Medicina et Pharmacologia Experimentalis. International Journal of Experimental Medicine. 15 (4): 329–43. doi:10.1159/000135886. PMID 6012765.
  3. ^ Miller L, Napoli M, O'Dell TB (April 1967). "Pharmacological evaluation of a potential psychotherapeutic agent: cyprolidol, a pyridylcyclopropane derivative". Archives Internationales de Pharmacodynamie et de Therapie. 166 (2): 313–323. PMID 4963240.
  4. ^ Hekimian LJ, Gershon S, Floyd A (June 1969). "Cyprolidol and imipramine: a double-blind controlled study in endogenous depression". Arzneimittel-Forschung. 19 (6): 955–956. PMID 4896165.
  5. ^ Korol B, Brown ML, Sletten IW (November 1966). "Effects of a new antidepressant cyprolidol (IN-1060) upon the blood pressure responses to autonomic drugs in conscious dogs". Current Therapeutic Research, Clinical and Experimental. 8 (11): 543–548. PMID 4963159.
  6. ^ Gray AP, Kraus H (February 1966). "Cyclopropylpyridines. Synthesis and Electronic Interaction 1". The Journal of Organic Chemistry. 31 (2): 399–405. doi:10.1021/jo01340a013.
  7. ^ "BE649145". Neisler Lab. 1964.
  8. ^ "AT250957B". 1966.
  9. ^ Lednicer D, Mitscher L. The Organic Chemistry of Drug Synthesis. Vol. 2. p. 31.

Public Domain This article incorporates public domain material from Cyprolidol hydrochloride. United States government. Retrieved 27 May 2025.